Kenvue (KVUE) Stock Forecast & Price Target

$23.13

-0.13 (-0.56%)

(As of 09/30/2024 ET)

Kenvue - Analysts' Recommendations and Stock Price Forecast (2024)

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.

Consensus Rating

Hold

Based on 11 Analyst Ratings

Sell
1

Hold
7

Buy
3

Based on 11 Wall Street analysts who have issued ratings for Kenvue in the last 12 months, the stock has a consensus rating of "Hold." Out of the 11 analysts, 1 has given a sell rating, 7 have given a hold rating, and 3 have given a buy rating for KVUE.

Consensus Price Target

$22.10
-4.45% Downside

According to the 11 analysts' twelve-month price targets for Kenvue, the average price target is $22.10. The highest price target for KVUE is $27.00, while the lowest price target for KVUE is $18.00. The average price target represents a forecasted downside of -4.45% from the current price of $23.13.

Get the Latest News and Ratings for KVUE and Related Stocks

Enter your email address to receive the latest news and analysts' ratings for Kenvue and its competitors.

KVUE Analyst Ratings Over Time

Type	Current Forecast 10/2/23 to 10/1/24	1 Month Ago 9/2/23 to 9/1/24	3 Months Ago 7/4/23 to 7/3/24	1 Year Ago 10/2/22 to 10/2/23
Strong Buy	0 Strong Buy rating(s)	0 Strong Buy rating(s)	0 Strong Buy rating(s)	0 Strong Buy rating(s)
Buy	3 Buy rating(s)	5 Buy rating(s)	6 Buy rating(s)	8 Buy rating(s)
Hold	7 Hold rating(s)	7 Hold rating(s)	7 Hold rating(s)	5 Hold rating(s)
Sell	1 Sell rating(s)	1 Sell rating(s)	1 Sell rating(s)	0 Sell rating(s)
Consensus Price Target	$22.10	$22.64	$23.09	$28.09
Forecasted Upside	-4.45% Downside	3.13% Upside	26.08% Upside	38.24% Upside
Consensus Rating	Hold	Hold	Hold	Moderate Buy

Does Elon Musk control the U.S. gov’t? (Ad)

Elon has been advising the government to reopen America’s nuclear facilities for years, and now, with the help of Biden’s ADVANCE act, these facilities are once again going back online just as he requested. One company is poised to benefit from America’s nuclear revival like no other. Elon Musk is one of the few people who knows this.

Watch this new documentary and you’ll discover what Elon knows,

KVUE Analyst Recommendations By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.

KVUE Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.

Kenvue Stock vs. The Competition

Type	Kenvue	Consumer Staples Companies	S&P 500
Consensus Rating Score	2.18	2.45	2.50
Consensus Rating	Hold	Hold	Hold
Predicted Upside	-4.45% Downside	492.64% Upside	6.15% Upside
News Sentiment Rating	Positive News See Recent KVUE News	Positive News	Positive News

Recent Analyst Forecasts and Stock Ratings

Rating

Upside/Downside

Action

Time Frame

Start Date

End Date

Show

Export to Excel

Date	Brokerage	Analyst Name	Action	Rating	Price Target	Upside/Downside on Report Date
9/24/2024	Jefferies Financial Group 2 of 5 stars		Initiated Coverage	Buy	$27.00	+17.29%
9/24/2024	Royal Bank of Canada 4 of 5 stars	N. Modi Subscribe to MarketBeat All Access for the recommendation accuracy rating	Downgrade	Outperform ➝ Sector Perform	$24.00	+4.26%
9/23/2024	Piper Sandler 2 of 5 stars		Boost Target	Neutral ➝ Neutral	$20.00 ➝ $21.00	-8.77%
8/7/2024	Deutsche Bank Aktiengesellschaft Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target	Buy ➝ Buy	$23.00 ➝ $24.00	+14.72%
8/7/2024	JPMorgan Chase & Co. Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target	Overweight ➝ Overweight	$22.00 ➝ $24.00	+14.72%
8/7/2024	UBS Group Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target	Neutral ➝ Neutral	$20.00 ➝ $22.00	+5.36%
Get the Latest News and Ratings for KVUE and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Kenvue and its competitors with MarketBeat's FREE daily newsletter.
7/10/2024	Citigroup Subscribe to MarketBeat All Access for the recommendation accuracy rating		Lower Target	Neutral ➝ Neutral	$21.00 ➝ $20.00	+13.06%
5/8/2024	HSBC Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target	Hold ➝ Hold	$20.00 ➝ $21.00	+3.09%
4/11/2024	Sanford C. Bernstein Subscribe to MarketBeat All Access for the recommendation accuracy rating		Initiated Coverage	Underperform	$18.00	-11.02%
4/3/2024	William Blair Subscribe to MarketBeat All Access for the recommendation accuracy rating	J. Andersen Subscribe to MarketBeat All Access for the recommendation accuracy rating	Initiated Coverage	Market Perform
3/1/2024	The Goldman Sachs Group Subscribe to MarketBeat All Access for the recommendation accuracy rating		Initiated Coverage	Buy ➝ Neutral	$20.00	+5.24%
9/7/2023	Canaccord Genuity Group Subscribe to MarketBeat All Access for the recommendation accuracy rating		Initiated Coverage	Buy	$28.00	+25.06%
9/6/2023	Argus Subscribe to MarketBeat All Access for the recommendation accuracy rating		Initiated Coverage	Hold
7/25/2023	Edward Jones Subscribe to MarketBeat All Access for the recommendation accuracy rating		Initiated Coverage	Buy
5/30/2023	BNP Paribas Subscribe to MarketBeat All Access for the recommendation accuracy rating		Initiated Coverage	Neutral	$28.00	+6.46%
5/30/2023	Bank of America Subscribe to MarketBeat All Access for the recommendation accuracy rating		Initiated Coverage	Buy	$30.00	+14.07%

Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Tuesday at 09:24 AM ET.

Should I Buy Kenvue Stock? KVUE Pros and Cons Explained

These pros and cons were generated based on recent news and financial data from MarketBeat in order to provide readers with the fastest and most accurate insights. They were last updated on Monday, September 30, 2024. Please send any questions or comments about these Kenvue pros and cons to contact@marketbeat.com.

Kenvue
Bull Case

Here are some ways that investors could benefit from investing in Kenvue Inc.:

Kenvue Inc. has recently increased its dividend from $0.20 to $0.205, indicating a positive outlook on the company's financial health and commitment to rewarding shareholders.
Analysts have given Kenvue Inc. an average rating of "Hold" with a price target of $21.44, suggesting stability and potential growth in the stock price.
Kenvue Inc. reported a net margin of 7.23% and a return on equity of 21.80%, showcasing strong financial performance and efficiency in utilizing shareholder equity.
The company's stock price has been trading consistently above its 50-day and 200-day moving averages, indicating positive momentum and investor confidence in the company's future prospects.
Kenvue Inc. operates in three segments: Self Care, Skin Health and Beauty, and Essential Health, diversifying its revenue streams and potentially reducing risk for investors.

Kenvue
Bear Case

Investors should be bearish about investing in Kenvue Inc. for these reasons:

Despite positive ratings and price targets, Kenvue Inc. has a payout ratio of 105.13%, which may indicate a high dividend payout relative to earnings and could potentially limit future growth or investment in the company.
While the company has shown stability, the stock has a beta of 1.40, indicating higher volatility compared to the market average, which may lead to increased risk for investors during market fluctuations.
One research analyst has rated the stock with a sell rating, suggesting some market participants have concerns about the company's performance or future outlook.
Kenvue Inc.'s revenue was down .3% on a year-over-year basis, indicating a slight decline in top-line growth, which could impact future earnings and stock price performance.
The company's debt-to-equity ratio of 0.69 may be a cause for concern as it indicates a moderate level of debt that needs to be managed effectively to avoid financial strain or increased interest costs.

KVUE Forecast - Frequently Asked Questions

: According to the research reports of 11 Wall Street equities research analysts, the average twelve-month stock price forecast for Kenvue is $22.10, with a high forecast of $27.00 and a low forecast of $18.00.
: 11 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Kenvue in the last year. There is currently 1 sell rating, 7 hold ratings and 3 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "hold" KVUE shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in KVUE, but not buy additional shares or sell existing shares.
: According to analysts, Kenvue's stock has a predicted downside of -4.45% based on their 12-month stock forecasts.
: Over the previous 90 days, Kenvue's stock had 1 downgrade by analysts.
: Kenvue has been rated by research analysts at Citigroup, Deutsche Bank Aktiengesellschaft, Jefferies Financial Group, JPMorgan Chase & Co., Piper Sandler, Royal Bank of Canada, and UBS Group in the past 90 days.
: Analysts like Kenvue less than other "consumer staples" companies. The consensus rating score for Kenvue is 2.18 while the average consensus rating score for "consumer staples" companies is 2.45. Learn more on how KVUE compares to other companies.